v
Search
Advanced Search

Publications > Journals > Journal of Translational Gastroenterology> About the journal

Aims and Scope

Journal of Translational Gastroenterology  (JTG) dedicates to improving clinical diagnosis and treatment, advancing understanding of the molecular mechanisms, and promoting translation from bench to bedside of gastrointestinal, hepatobiliary, and pancreatic diseases. The aim of JTG is to provide a forum for the exchange of ideas and concepts on basic, translational, and clinical aspects of gastroenterology, and promote cross-disciplinary research and collaboration. 

JTG publishes up-to-date research in gastroenterology with:

  • Original research article
  • Review article
  • Short communication
  • Clinical trial
  • Consensus & Guideline
  • Systematic review & Meta-analysis
  • Editorial
  • Commentary
  • Case report

Topics of interest include but are not limited to:

  • Esophagus
  • Colon and small intestine
  • Inflammatory bowel disease
  • Endoscopy
  • Functional gastrointestinal diseases
  • Pathology
  • Gut microbiota
  • Gastrointestinal immunology
  • Gastrointestinal oncology
  • Liver
  • Neurogastroenterology
  • Pediatric gastroenterology
  • Cholestatic and biliary disease
  • Pancreaticobiliary duct
  • Nutrition and obesity
  • Gastrointestinal epidemiology & public health


Open Access

Journal of Translational Gastroenterology (JTG) adopts open access publishing model, and all articles are distributed under the terms of the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/). Under this license, anyone may copy, distribute, or reuse these articles for non-commercial purposes, provided the original work is properly cited. Manuscripts submitted for publication in an open access journal are subject to the same rigorous peer-review and quality control as in scholarly subscription journals.

JTG recognizes the distinct advantages of using an open access publication model to timely disseminate innovative and important research findings. Unrestricted free access to our publications is anticipated to foster intellectual discourse across geographic and disciplinary boundaries. To support the success of our open access approach, we ensure the integrity and high quality of research published in our journal by practicing a rigorous peer review process and by following strict guidelines for ethics in publication and in conduct of the scientific process.

Publication Criteria

All manuscripts submitted to JTG must meet the following criteria for publication:

  • Topics with timely relevance to the general field or specialties in basic and clinical medicine;
  • A must-have section of “hypothesis/ future direction/ prospect/ prediction” included for all research and review articles;
  • Results and findings that have not been previously published elsewhere;
  • Research performed with adherence to accepted global standards for ethics in the scientific process;
  • Ethical reporting of data to protect the rights and privacy of study participants;
  • Appropriate statistical analyses, with sufficient descriptions of all statistical methods used;
  • Conclusions supported by the data presented;
  • All funding sources and their roles cited;
  • For clinical trials, the registration number cited;
  • Manuscript written in standard American (US) English and formatted according to the journal-specific guidelines;
  • No instances of textual plagiarism, including ‘text recycling/self-plagiarism”.
Publishing Schedule
JTG currently publishes 4 issues a year, in March, June, September and December.
Journal Metrics
JTG Metrics (2023)
Acceptance rate: 30% 
Median time from submission to first decision: 19 days 
Median time from acceptance to online publishing: 20 days
Revenue Sources

JTG adopts the open access publishing model. Revenues are generated from article processing charges (APC), permission fees, and reprints.

Ownership
JTG is owned and published by Xia & He Publishing Inc.
Contact us
Editorial Office

Managing Editor: Lisa Chen
Postal Address: Room 505, Building B1, Bio-innovation Park, No. 666 High-tech Road, East Lake High-tech Development Zone, Wuhan, China

Publisher 

Xia & He Publishing Inc.
Tel: +1-409-420-2868 

US Office
Address: 14090 Southwest Freeway, Suite 300, Sugar Land, Texas 77478, USA

China Office
Address: Room 505, Building B1, Bio-innovation Park, No. 666 High-tech Road, East Lake High-tech Development Zone, Wuhan, China

Back to Top